Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the international geriatric radiotherapy group

HIGHLIGHTS

• What: The combination of SBRT and immunotherapy may be beneficial for older patients with non-metastatic renal cancer who are not candidates for surgical resection or decline nephrectomy.
• Who: Nam P. Nguyen from the University, China have published the article: Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group, in the Journal: (JOURNAL)
• Future: Again the combination of lenvatinib and pembrolizumab seems to be most promising but needs to be confirmed in future prospective studies . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.